AstraZeneca advances weight-loss pill to take aim at obesity leaders



Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly



Source link

You may be interested

Leave a Reply

Your email address will not be published. Required fields are marked *